The effect of altering haemodynamics on the plasma concentrations of natriuretic peptides in heart failure-Reference-Cited by-同舟云学术

The effect of altering haemodynamics on the plasma concentrations of natriuretic peptides in heart failure

Published:2006-10 Issue:6 Volume:8 Page:628-633
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Larsen A.I.¹,Dickstein K.¹,Ahmadi N.S.²,Aarsland T.³,Kvaløy J.T.⁴,Hall C.²

Affiliation:

1. University of Bergen, Cardiology Division, Stavanger University Hospital; N-4001 Stavanger Norway

2. Akershus University Hospital, University of Oslo; Norway

3. Hjertelaget Research Foundation; Rogaland Norway

4. Department of Mathematics and Natural Science, University of Stavanger, Division of Research and Human Resources, Stavanger University Hospital; Norway

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure;Dickstein;Am J Cardiol,1995

2. Bedside B-type natriuretic peptide and functional capacity in chronic heart failure;Jourdain;Eur J Heart Fail,2003

3. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction;Richards;Circulation,2003

4. Plasma N-terminal atrial natriuretic factor: a predictor of survival in patients with congestive heart failure;Dickstein;J Card Fail,1997

5. Comparative vasoactive effects of native and synthetic atrial natriuretic factor (NAF);Garcia;Biochem Biophys Res Commun,1984

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of the Cardiac Structure and Function of Conscious D2.B10-Dmdmdx/J (D2-mdx) mice from 16–17 to 24–25 Weeks of Age;International Journal of Molecular Sciences;2023-07-22

2. Current Status and Trends of Research on Anthracycline-Induced Cardiotoxicity from 2002 to 2021: A Twenty-Year Bibliometric and Visualization Analysis;Oxidative Medicine and Cellular Longevity;2022-08-11

3. The Effects of Sodium-Glucose Cotransporter-2 Inhibitors (SLGT-2i) on Cardiovascular and Renal Outcomes in Non-diabetic Patients: A Systematic Review;Cureus;2022-05-30

4. Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial;American Heart Journal;2020-10

5. NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies;Clinical Biochemistry;2013-08